Cerevel Therapeutics Holdings Inc

NASDAQ:CERE   4:00:00 PM EDT
27.21
-1.10 (-3.89%)
4:01:23 PM EDT: $27.21 0.00 (0.00%)
Earnings Announcements

Cerevel Therapeutics Reports Third Quarter Financial Results

Published: 11/08/2022 12:31 GMT
Cerevel Therapeutics Holdings Inc (CERE) - Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates.
Qtrly Loss per Share $0,66.
Cash, Cash Equivalents and Marketable Securities of $1,030 Million As of Sept 30.
Q3 Earnings per Share View $-0.62 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.